Kinsa Health raises $17M to expand smart products
SAN FRANCISCO – Kinsa Health will use $17 million in Series B fundraising to develop additional smart products and services to expand on its line of smart thermometers and mobile app. The current Bluetooth-enabled products offer health tracking and guidance, and a one-second temperature read. The company has raised $28.6 million in total funding.
Dementia app aims to improve quality of life
CHICAGO – A new app developed by the College of Nursing at the University of Illinois can help improve the quality of life for individuals with dementia and their families and caregivers, its developers say. “We felt the best way to reach the largest audience possible to improve the public’s ability to understand the disease was to develop this app,” said Valerie Gruss, clinical associate professor of biobehavioral health science and co-developer of the app, in a statement. The “Dementia Guide Expert for Families” provides information about dementia, including the various types, contributing factors, risks, symptoms, stages, diagnosis, tests, treatment, management and communication techniques. It also allows users to find appropriate providers, and community support and resources. “This allows people to recognize early warning signs, enhance their ability to manage or self-manage the symptoms of dementia and adopt behaviors to improve their health,” said Gruss.
Philips expands Dream family of respiratory devices
AMSTERDAM, the Netherlands – Royal Philips has expanded its Dream Family of products with the DreamStation Advanced Therapies BiPAP autoSV and AVAPS devices to provide care for patients with complex ventilation needs. The devices are currently available in select markets in the U.S., France and Australia, and will be available globally by the end of this year. They aim to deliver optimal ventilation with minimal intervention so patients experience comfortable, restful sleep and quality of life. The DreamStation Advanced Therapies devices are fully integrated through the Philips Encore Anywhere patient management tool, providing automated support for the patient’s changing needs, as well as remote monitoring capabilities support for physicians, HME providers and caretakers to intervene when needed to minimalize adverse effects. The Dream Family of products launched in 2015 as a full suite of sleep solutions that connect and support the patient, clinician and homecare provider to enhance patient care and quality of life.
Northwell Health partners with Force Therapeutics for enhanced patient experience
NEW HYDE PARK, N.Y. – Northwell Health and Force Therapeutics have signed a two-year agreement to implement a customized, video-based software platform for better monitoring and communication between patients and providers following orthopedic surgeries. “We see immense potential in the applications of the software platform because we can quickly address many of the main causes of complications before, during and after joint replacement surgery,” said Dr. Giles Scuderi, vice president of Northwell’s orthopedic service line, in a statement. By using Force’s technology, Northwell is aiming to improve outcomes, reduce hospital readmissions, increase the number of patients being discharged home as opposed to rehabilitation and decrease health care costs. To date, seven Northwell hospitals are using the software platform and 1,300 patients are enrolled in the program. The technology is expanding to other Northwell hospitals and orthopedic practices.
Biotricity chooses Providence Enterprises to make devices
REDWOOD CITY, Calif. – Health care technology company Biotricity Inc. has selected contract manufacturer Providence Enterprise to mass produce its medical grade and connected health care devices. “We are thrilled that Providence is ready to provide full production of our medical-grade devices and to help diagnose patients by tracking and reporting on cardiac activity in real-time,” said Waqaas Al-Siddiq, founder and CEO of Biotricity, in a statement. Specifically, Biotricity will outsource much of its connected device supply chain to Providence to reduce costs, improve performance and meet the expected demand of Bioflux, a remote cardiac monitoring system that physicians will use for testing and diagnostic care.
Cohero Health closes on $10.5M in funding
NEW YORK – Digital health company Cohero Health will use $10.5 million in Series A funding to expand its BreatheSmart respiratory disease management platform. The platform connects to the company’s smartphone-connected spirometer, which measures lung function, tracks inhaler use and gives medication reminders. The funding will support broader commercialization of the hardware and software of the platform, said Melissa Manice, co-founder and CEO of Cohero Health, in a statement.
Medisafe raises $14.5M to expand product, open new office
BOSTON – Medisafe has raised $14.5 million in Series B funding to support growth and expansion. The company provides a personalized medication management platform with more than 3.5 million patient and caregiver registered users.
“We will use the new capital to hire the best talent, enhance the platform’s capabilities and achieve our ambitious expansion goals globally,” said Omri Shor, CEO and co-founder of Medisafe, in a statement.
Medisafe’s platform educates patients about their condition and medications, shares their progress, offers tips, and curates prescription coupons and special offers.
Physicians can invite their patients to connect through the platform. Adherence information and other health data is automatically brought into their dashboard.
Medisafe will use the new funding to grow its sales and marketing teams, expand the platform’s capabilities and open a London office to capitalize on growing demand.
The company announced an expansion of its offering to pharmaceutical and life sciences companies in October.
CHI develops tool for health tech developers to navigate HIPAA
WASHINGTON – The Connected Health Initiative has created a tool to help health technology entrepreneurs understand whether they need to comply with the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
“You can comply with the law relatively easily once you know the rules,” said Morgan Reed of CHI in a blog post.
HIPAA Check is an interactive tool to help developers determine how their technology fits within the HIPAA framework. It takes the user through a series of questions, which include the definitions of terms they need, a video explaining the concept of “on behalf of,” and links to resources and places to find additional information.
“To be successful, health tech start-ups must protect the privacy and security of patients, but for many companies, it’s a constant struggle to figure out where they fit under HIPAA,” Reed said.
Once a user has completed HIPAA Check, they have the option to receive a full report, which provides all the questions answered and how they were answered.
“While the information provided through the tool, and subsequently, the report, should not be considered legal advice, the output of HIPAA Check will provide clarity for many companies as to their responsibilities under HIPAA,” said Reed.
The report gives companies the documentation they might need to show prospective clients, users and investors that they understand their role in protecting the privacy and security if patients who may utilize the technology, Reed said.
Arthritis Research UK launches Watson-powered virtual assistant
LONDON – Arthritis Research UK and IBM have introduced a Watson-powered “virtual personal assistant” to provide information and advice to people living with arthritis.
“We’re confident that this new virtual assistant will help more people push back the ways arthritis limits their lives,” said Liam O’Toole, Arthritis Researh UK CEO, in a statement.
The charity has teamed up with IBM to ensure people seeking help will have access to personalized information from the Arthritis Research UK website, delivered in a form that feels like a natural conversation.
There are currently 300 people with arthritis testing the service and providing feedback to Arthritis Research UK prior to its public launch on the charity’s website later this year.
The digital personal assistant was developed over five months using Arthritis Research UK’s research-based knowledge and expertise, as well as advice from health care professionals, people with arthritis and IBM Watson’s cognitive computing experts.
“Arthritis Research UK’s use of Watson APIs is a model for organizations thinking about how they might integrate cognitive computing into their services to positively impact the lives of people living with a serious health condition,” said Cameron Brooks, IBM European Director for Watson in the Public Sector, in a statement.